Twitter Beğeni Hilesi

Fantastic to see the SCALOP 2 trial results published: dose-escalated CRT may improve local tumour control and is well tolerated when used as consolidative treatment in LAPC but does not impact OS. Nelfinavir use does not improve PFS kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

My #EdFringe debut begins tomorrow: underbellyedinburgh.co.uk/events/event/w…

If you are in Edinburgh during the month of August, go and see Will Sebag-Montefiore - everyone tells me he is very funny - I could not possibly comment!

Scientists need more time to think” - I fully agree! A brilliant thought piece in nature discussing the challenge of balancing email and instant messaging whilst protecting thinking time rings true and applies not only to scientists but other staff groups in academia.

After eleven years, it's time to update my London Underground concentric-circles-and-spokes map. Completely redrawn from centre to edges, it's so much better than before, and more geographically accurate than the official map.

The Edinburgh Festival Fringe Edinburghfest is a fantastic way to unwind and enjoy being entertained by a wealth of talent across a diverse range of backgrounds, set against the backdrop of the beautiful historic city of @edinburgh! #comedy #laughter #music #fun

The ESMO - Eur. Oncology Academy meeting provides an ideal environment for an in-depth learning experience focused on evidence-based practice across oncology. A great turn out with 340 delegates from 54 countries in the beautiful city of Zurich! 🇨🇭 University of Zurich #oncology #patients #treatment

Horrified to discover I used the word "gumption" in an interview with the The Guardian 🤢 theguardian.com/stage/article/…

I’m so delighted to see this news. Kevin Blyth 💙 works tirelessly and creatively to improve outcomes for #mesothelioma patients. Congratulations! 🥂🎉 UofG Cancer Sciences Cancer Research UK in Scotland

Fantastic to host Robert Atkinson, Global Clinical Operations Director ⁦Adlai Nortye⁩, who fund the rectal cancer ARTEMIS ph II trial, and show him our cutting-edge radiotherapy research and innovation. ⁦Leeds CTRU⁩ ⁦CRUK Radnet Leeds Centre⁩ ⁦Leeds Teaching Hospitals⁩

🔥LONDON TRANSFER🔥

If you are in central London on Thursday 5th September go and see Will Sebag-Montefiore in Will of The People at the Cavendish Square Underbelly festival - 9pm! underbellyfestival.com/events-display…

Very exciting practice changing results of POD1UM that show adding retiflanimab to carbo/taxol improves PFS and OS as first line treatment for metastatic anal cancer - superbly presented by Sheela Rao. Great news for patients. ESMO - Eur. Oncology Incyte The Royal Marsden NHS Foundation Trust Leeds Teaching Hospitals

The Leeds anal cancer team en route to the practice changing POD1UM trial presentation ⁦ESMO - Eur. Oncology⁩ in Barcelona! We are proud to have been the top UK recruiting site! ⁦University of Leeds⁩ ⁦University of Leeds⁩ ⁦Incyte⁩

Excited to be part of the “Eyes to the Future” Presidential Symposium session on Monday 15th September. If you are at #ESMO24, do join us in the Barcelona auditorium for a look to the future including organ preservation, AI, epigenetics and overcoming cancer reisitance ESMO - Eur. Oncology

How can we preserve organs while treating cancer? 🏥 Explore the with systemic therapies that could offer solutions with David Sebag-Montefiore David Sebag (he/him) 🇺🇦💙 | University of Leeds | #ESMO2024 | #CRUKFunded

Be sure to attend the session chaired by Christopher Williams 🪑 He’ll be discussing the new technologies on the horizon for #ColorectalCancer 🎴 University of Leeds | #ESMO2024 | #CRUKFunded

Excellent talk and case presentation by Alexandra G in chemoradiotherapy anal cancer session ESMO - Eur. Oncology in Barcelona including an update on the Science and Innovation at Cancer Research UK Stand Up To Cancer UK ACT 3,4,5 trial #ESMO2024 University of Leeds Leeds Research & Innovation CRUK Radnet Leeds Centre Leeds CTRU #radiotherapy #analcancer

Excellent talk by Jenny Seligmann on neo-adjuvant chemotherapy for MSS colon cancer at the ESMO - Eur. Oncology meeting in Barcelona addressing the critically important questions -“Who, What and How Long”? University of Leeds Leeds Teaching Hospitals